Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maomao Gu"'
Autor:
Xumian Qiao, Hassan Siddique, Xinhua Li, Song Zhu, Sifei Liu, Maomao Gu, Haoyu Yang, Donghui Zhang, Qiang Zhao
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract A facile and environmentally friendly ion exchange-assisted surface passivation (IASP) strategy is presented for synthesizing red emitting Mn4+-activated fluoride phosphors. A substantial, pristine Mn4+-free shell layer, applied as a coating
Externí odkaz:
https://doaj.org/article/55de23395be04877b6d61d7bea36a46a
Autor:
Xiaoge Gao, Pin Jiang, Qian Zhang, Qian Liu, Shuangshuang Jiang, Ling Liu, Maomao Guo, Qian Cheng, Junnian Zheng, Hong Yao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/3ca2c31e4c894c83adb7f604248c3f06
Application of Three-dimensional Visualization Fused with Ultrasound for Percutaneous Renal Puncture
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract We present here the three-dimensional (3D) visualization fused with ultrasound and to evaluate its clinical application effect preliminarily. One hundred and eighteen patients with renal calculi in our hospital from September 2017 to Decembe
Externí odkaz:
https://doaj.org/article/45ac1473496943b4a306d6ddf89eb9e8
Autor:
Hongbo Yu, Zheng Xu, Maomao Guo, Weiwan Wang, Weican Zhang, Sudong Liang, Zhibin Xu, Jun Ye, Gangyi Zhu, Chenyang Zhang, Jianzhong Lin
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Docetaxel resistance affects prognosis in advanced prostate cancer (PCa). The precise mechanisms remain unclear. Transcription factor Forkhead box M1 (FOXM1), which participates in cell proliferation and cell cycle progression, ha
Externí odkaz:
https://doaj.org/article/8a595272e6fc44698b0bbb1781ca8cd3
Autor:
Xiaoge Gao, Pin Jiang, Qian Zhang, Qian Liu, Shuangshuang Jiang, Ling Liu, Maomao Guo, Qian Cheng, Junnian Zheng, Hong Yao
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-15 (2019)
Abstract Background Tumor targeting small molecular inhibitors are the most popular treatments for many malignant diseases, including cancer. However, the lower clinical response and drug resistance still limit their clinical efficacies. HGFK1, the f
Externí odkaz:
https://doaj.org/article/0bce2f437e7e4530938f66023c5c6824